RPS19 and depressive symptom measurement: In particular, ribosomal protein S19, ribosomal protein S12, ribosomal protein S14, vimentin, and ubiquitin-like modifier activating enzyme 1 mediated the therapeutic effects of EXD on depression and hippocampal damage.